Logo 1 Logo 2

Clinical Trial Details

Trial ID: L3146
Source ID: NCT00689026
Associated Drug: Lubiprostone
Title: Efficacy of Lubiprostone in Combination With Standard PEG Preparation
Acronym:
Status: TERMINATED
Study Results: YES
Results: https://ClinicalTrials.gov/show/NCT00689026/results
Conditions: Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2
Interventions: DRUG: Lubiprostone|OTHER: Polyethylene glycol with electrolytes
Outcome Measures: Primary: The Percentage of Patients That Received a Quality of Colonoscopy Preparation Rating of <=2 on a 5 Point Likert Scale., The quality of colonoscopy preparations as rated by blinded colonoscopists on a 5-point Likert Scale where 1=excellent, 2=good, 3=fair, 4=poor, 5=inadequate. It was expected that at least 100 patients would complete the trial., The outcome was measured at the completion of the colonscopy procedure. Average time to completion two hours |
Sponsor/Collaborators: Sponsor: Augusta University | Collaborators: Takeda Pharmaceuticals North America, Inc.
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases:
Enrollment: 60
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: DIAGNOSTIC
Start Date: 2008-05
Completion Date: 2010-03
Results First Posted: 2014-10-20
Last Update Posted: 2014-10-20
Locations: Medical College of Georgia, Augusta, Georgia, 30912, United States
URL: https://clinicaltrials.gov/show/NCT00689026